A randomized three-year clinical trial recently released shows fish oil high in omega-3 fatty acids provides statistically significant benefit for those genetically predisposed to Alzheimer’s. McCance Center’s Dr. Gene Bowman is senior corresponding author.

"This is the first dementia prevention trial to use modern prevention tools, such as a blood test and brain scan to identify not only people at high risk for dementia but also what features determine response to a specific nutritional intervention," said Dr. Bowman. "The fact that neuronal integrity breakdown was slowed in people randomized to omega-3 treatment who are also at high genetic risk for Alzheimer’s disease is remarkable and warrants a larger clinical trial in more diverse populations in the future."

Bowman is head of the McCance Center Clinical Trials Platform and Brain Nutrition Laboratory and previously worked at OHSU, where he secured federal funding to conduct the clinical trial.

Learn more.

Type

Centers and Departments

Topics